Adelaide Research & Scholarship: Search

Search

Results 11-20 of 22 (Search time: 0.002 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2013	Lipidomics: Opportunities to identify new causal mechanisms and therapeutics for atherosclerosis	Puri, R.; Duong, M.; Kataoka, Y.; Uno, K.; Nicholls, S.
	2013	Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial	Lincoff, M.; Tardif, J.; Neal, B.; Nicholls, S.; Ryden, L.; Schwartz, G.; Malmberg, K.; Buse, J.; Henry, R.; Wedel, H.; Weichert, A.; Cannata, R.; Grobbee, D.
	2013	Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute st-segment elevation myocardial infarction	Madder, R.; Goldstein, J.; Madden, S.; Puri, R.; Wolski, K.; Hendricks, M.; Sum, S.; Kini, A.; Sharma, S.; Rizik, D.; Brilakis, E.; Shunk, K.; Petersen, J.; Weisz, G.; Virmani, R.; Nicholls, S.; Maehara, A.; Mintz, G.; Stone, G.; Muller, J.
	2013	Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database	Palmer, M.; Nicholls, S.; Lundman, P.; Barter, P.; Karlson, B.
	2013	C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy	Puri, R.; Nissen, S.; Libby, P.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2013	Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy	Puri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2013	Coronary endothelium-dependent vasoreactivity and atheroma volume in subjects with stable, minimal angiographic disease versus non-ST-segment- elevation myocardial infarction: an intravascular ultrasound study	Puri, R.; Nicholls, S.; Nissen, S.; Brennan, D.; Andrews, J.; Liew, G.; Nelson, A.; Carbone, A.; Copus, B.; Tuzcu, E.; Beltrame, J.; Worthley, S.; Worthley, M.
	2013	Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy - a meta-analysis of 11 randomized controlled trials involving 21,295 participants	Barylski, M.; Nikfar, S.; Mikhailidis, D.; Toth, P.; Salari, P.; Ray, K.; Pencina, M.; Rizzo, M.; Rysz, J.; Abdollahi, M.; Nicholls, S.; Banach, M.
	2013	Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials	Nikolic, D.; Nikfar, S.; Salari, P.; Rizzo, M.; Ray, K.; Pencina, M.; Mikhailidis, D.; Toth, P.; Nicholls, S.
	2013	A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)	Maki, K.; Orloff, D.; Nicholls, S.; Dunbar, R.; Roth, E.; Curcio, D.; Johnson, J.; Kling, D.; Davidson, M.